Panagiota Moutsatsou
Papers
1
Total Citations
17
H-Index
1
About
Dr. Panagiota Moutsatsou is a pioneering figure in the field of advanced therapeutic medicinal products (ATMPs), with a focused expertise in the automation and scalable manufacture of cell therapies. Her landmark work, "Needle to needle robot‑assisted manufacture of cell therapy products" (2022, 17 citations), addresses a critical bottleneck in the industry: the transition from costly, high-risk manual cell expansion to fully automated, Good Manufacturing Practice (GMP)-compliant production. This contribution lays the foundation for a new paradigm in biomanufacturing, enabling the large-scale, high-quality production of cells needed to treat previously untreatable diseases. By integrating robotics and process engineering with cell biology, Dr. Moutsatsou’s research directly impacts the clinical translation of ATMPs, reducing production risks and costs. Her work is essential reading for students and researchers interested in the intersection of automation, bioprocessing, and regenerative medicine, marking her as a key innovator in making life-saving cell therapies more accessible and reproducible.
Research Focus
Key Achievements
Top Papers
- 1